The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Radiation Enhances Regulatory T Cell Representation
Open accessAbstract
PURPOSE Immunotherapy (IT) could be a useful adjunct to standard cytotoxic therapies such as radiation in patients with micrometastatic disease although successful integration of IT into treatment protocols will require further understanding of how standard therapies affect the generation of anti-tumor immune responses. This study was undertaken to evaluate the impact of radiation therapy on immunosuppressive T regulatory (Treg) cells. MATERIALS and METHODS Tregs were identified as a CD4+CD25hiFoxp3+ lymphocyte subset and their fate followed in a murine TRAMP-C1 model of prostate cancer in mice with and without radiation therapy. RESULTS CD4+CD25hiFoxp3+ Treg cells increased in immune organs following local leg or whole body radiation. A large part, but not all, of this increase following leg-only irradiation could be ascribed to radiation scatter and Tregs being intrinsically more radiation resistant than other lymphocyte subpopulations resulting in their selection. Their functional activity on a per cell basis was not affected by radiation exposure. Similar findings were made with mice receiving local RT to murine prostate tumors growing in the leg. The importance of the Treg population in the response to RT was shown by systemic elimination of Tregs, which greatly enhanced radiation-induced tumor regression. CONCLUSIONS We conclude that Tregs are more resistant to radiation than other lymphocytes resulting in their preferential increase. Treg cells may form an important homeostatic mechanism for tissues injured by radiation, and in a tumor context may assist in immune evasion during therapy. Targeting this population may allow enhancement of radiotherapeutic benefit through immune modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Dannull, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25947 · Cited by 989
Fontenot, J. D., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1179 · Cited by 950
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
Martin, M., Lefaix, J.-L., & Delanian, S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00435-1 · Cited by 657
IL-2, Regulatory T Cells, and Tolerance
Nelson, B. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.3983 · Cited by 556
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Sitkovsky, M. V., Kjaergaard, J., Lukashev, D., & Ohta, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0229 · Cited by 253
Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen
Haribhai, D., Lin, W., Relland, L. M., Truong, N., Williams, C. B., & Chatila, T. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2961 · Cited by 244
Antigen-Specific FoxP3-Transduced T-Cells Can Control Established Type 1 Diabetes
Jaeckel, E., von Boehmer, H., & Manns, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.306 · Cited by 232
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation Therapy
Schaue, D., Comin-Anduix, B., Ribas, A., Zhang, L., Goodglick, L., Sayre, J. W., Debucquoy, A., Haustermans, K. M., & McBride, W. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4462 · Cited by 145
Self-citationAdenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells
Sitkovsky, M. V., Lukashev, D. E., Deaglio, S., Dwyer, K. M., Robson, S. C., & Ohta, A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.23 · Cited by 129
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice
Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125
Impact of localized radiotherapy on blood immune cells counts and function in humans
Belka, C., Ottinger, H. D., Kreuzfelder, E., Weinmann, M., Lindemann, M., Lepple‐Wienhues, A., Budach, W., Grosse‐Wilde, H., & Bamberg, M. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00130-3 · Cited by 123
Liao, Y., Wang, C., Butterfield, L. H., Economou, J. S., Ribas, A., Meng, W. S., Iwamoto, K. S., & McBride, W. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2462 · Cited by 118
Self-citationNorth, R. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.5.1652 · Cited by 101
Control of IFN-αA by CD73: Implications for Mucosal Inflammation
Louis, N. A., Robinson, A., MacManus, C. F., Karhausen, J., Scully, M. M., & Colgan, S. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4246 · Cited by 94
Kudo‐Saito, C., Schlom, J., Camphausen, K. A., Coleman, C. N., & Hodge, J. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2237 · Cited by 84
der Meeren, A. V., Monti, P., Vandamme, M., Gaugler, M., Wysocki, J., & Griffiths, N. M. (2005) · Radiation Research · doi:10.1667/rr3293 · Cited by 68
Tsai, C., Hong, J.-H., Hsieh, K.-F., Hsiao, H.-W., Chuang, W.-L., Lee, C.-C., McBride, W. H., & Chiang, C.-S. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700977 · Cited by 15
Self-citationHeightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis
Sheth, S. G., Bleibel, W., Thukral, C., A-Rahim, Y. I., Beldi, G., Csizmadia, E., & Robson, S. C. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9154-2 · Cited by 12
Cited by
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum, R. R., Liang, H., Deng, L., & Fu, Y.-X. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,070
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Formenti, S. C., & Demaria, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs629 · Cited by 1,053
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Sharabi, A. B., Lim, M., DeWeese, T. L., & Drake, C. G. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00007-8 · Cited by 899
Metadata
- Authors
- Kachikwu, E. L., Iwamoto, K. S., Liao, Y.-P., DeMarco, J. J., Agazaryan, N., Economou, J. S., McBride, W. H., & Schaue, D.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 81
- Issue
- 4
- Pages
- 1128-1135
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2168244200
- Cited by
- 429
- References
- 31
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.